期刊
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
卷 43, 期 4, 页码 1546-1551出版社
ELSEVIER
DOI: 10.1016/j.jpba.2006.11.013
关键词
buparvaquone; atenolol; propranolol; quinidine; verapamil; in situ intestinal permeability; P-glycoprotein; RP-HPLC
A simple, sensitive and specific reversed phase high performance liquid chromatographic (R-P-HPLC) method with UV detection at 251 nm was developed for simultaneous quantitation of buparvaquone (BPQ), atenolol, propranolol, quinidine and verapamil. The method was applicable in rat in situ intestinal permeability study to assess intestinal permeability of BPQ, a promising lead compound for Leishmania donovani infections. The method was validated on a C-4 column with mobile phase comprising ammonium acetate buffer (0.02 M, pH 3.5) and acetonitrile in the ratio of 30:70 (v/v) at a flow rate of 1.0 ml/min. The retention times for atenolol, quinidine, propranolol, verapamil and BPQ were 4.30, 5.96, 6.55, 7.98 and 8.54 min, respectively. The calibration curves were linear (correlation coefficient >= 0.996) in the selected range of each analyte. The method is specific and sensitive with limit of quantitation of 15 mu g/ml for atenolol, 0.8 mu g/ml for quinidine, 5 mu g/ml for propranolol, 10 mu g/ml for verapamil and 200 ng/ml for BPQ. The validated method was found to be accurate and precise in the working calibration range. Stability studies were carried out at different storage conditions and all the analytes were found to be stable. This method is simple, reliable and can be routinely used for accurate permeability characterization. (c) 2006 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据